La Vista, Nebraska – Streck announces the newest additions to the MDx-Chex^® line of molecular quality controls. MDx-Chex for CT/NG/TV and MDx-Chex for MVP (multi-plex vaginal panel) are ready-to-use, full-process molecular quality controls designed for sexual health workflow validation.

 MDx-Chex for CT/NG/TV and MDx-Chex for MVP feature instrument-agnostic design, making them compatible across multiple platforms. Each control contains intact, inactivated microorganisms suspended in a stabilized patient-like matrix to evaluate the entire molecular testing process from lysis to extraction to detection. Supplied in single-use vials that can be stored at room temperature, these controls cover multiple pathogens, helping labs achieve reliable performance and streamlined workflows.

 “Laboratories performing sexual health testing need controls they can trust to validate their entire workflow. This expansion of the MDx-Chex line reflects our continued commitment to providing reliable, ready-to-use solutions that ensure expected performance of molecular instrumentation and tests,” said Chris Connelly, Director of Business Segment – Molecular. “We’re proud to play a role in the fight against sexually transmitted infections.” 

 MDx-Chex for CT/NG/TV and MDx-Chex for MVP are available now. For more information, click here.

MDx-Chex for CT/NG/TV (RUO) and MDx-Chex for MVP (RUO) are for Research Use Only. Not for use in diagnostic procedures.

 About Streck, Inc.

Established in 1971, Streck provides solutions that ensure every result counts by empowering clinical and research laboratories to reliably deliver accurate results, advance diagnostics, and enable healthier, happier lives for patients everywhere. Streck products are manufactured in La Vista, Nebraska, and delivered to thousands of labs worldwide.